EHD Consortium

Dragutin Rafailovic

bossdach — Tue, 26 Aug 2025 17:02:58 +0000

Dr. Rafailović is an experienced Drug Safety Physician with a demonstrated delivery of medical, clinical, and scientific advisory expertise in clinical research studies and post marketing programs, signal detection and aggregated reporting. Skilled in medical review, medical writing, signal detection, medical monitoring, literature review, clinical research, and client/staff training.

Source

Majda Martinac

bossdach — Tue, 26 Aug 2025 17:02:28 +0000

Majda has ten years of experience in phase I-IV clinical trials and post-marketing pharmacovigilance, including various therapeutic areas and medicinal products. Areas of expertise include case processing, safety reporting, development of PV controlled documents (such as standard operating procedures, operating guidelines, safety management plans, etc), active participation and support in…

Source

Mike Larsen

bossdach — Tue, 26 Aug 2025 15:38:42 +0000

Mike Larsen has substantial and broad experience, including executive level positions, with global life science companies spanning start-up environments to Fortune 200 companies. Mike’s areas of expertise include Research and Development, Regulatory Affairs, Quality Systems and Clinical Studies for Class I through Class IV medical devices, pharmaceutical products and combination products.

Source

Gillian Carrington

bossdach — Tue, 26 Aug 2025 15:37:56 +0000

Gillian studied at the University of Oxford (Somerville) before converting to law. She practiced for many years in the City of London and European capitals as a regulatory lawyer, advising and supporting global companies in their regulatory operations and litigation cross-border. After moving into the life sciences field, she led the regulatory departments at a number of CROs…

Source